Latest news with #AEX
Business Upturn
4 days ago
- Business
- Business Upturn
76% of Indian Healthcare Professionals Are Optimistic That AI Can Improve Patient Outcomes: Philips Future Health Index 2025
Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and innovation, announced the India findings of its 10th annual Future Health Index (FHI) 2025 report. The findings point to a growing majority of healthcare professionals viewing artificial intelligence (AI) as a vital tool in the delivery of better patient care even as India faces rising healthcare demand and persistent workforce shortages. Business Wire India Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and innovation, announced the India findings of its 10th annual Future Health Index (FHI) 2025 report. The findings point to a growing majority of healthcare professionals viewing artificial intelligence (AI) as a vital tool in the delivery of better patient care even as India faces rising healthcare demand and persistent workforce shortages. According to the India findings of the Philips Future Health Index (FHI) 2025, 76% of Indian healthcare professionals (HCPs) are optimistic that AI can help improve patient outcomes – a clear sign of the increasing trust in digital transformation as a driver of quality healthcare. This year, the Future Health Index, one of the world's largest recurring healthcare research initiatives, captures insights from over 1,900 healthcare professionals and 16,000 patients across 16 countries. The India report draws insights from healthcare professionals across public and private sectors. The data highlights how AI is increasingly being perceived not merely as a tool for efficiency, but also to expand access, improve clinical quality, and reduce professional fatigue. Commenting on the India findings, Bharath Sesha, Managing Director, Philips Indian Subcontinent, said, ' India stands at a pivotal moment in healthcare transformation. What we're seeing today is a growing trust in AI not just as a tool for efficiency but as a catalyst for better clinical outcomes, broader access, and more empowered healthcare professionals. The findings from this year's Future Health Index India report reaffirm what we've long believed – that technology, when applied with purpose, can bridge the gap between capability and capacity. It is encouraging to see patients' readiness to embrace this transformation, and belief from over 80% Indian Healthcare professionals that AI could save lives by enabling early interventions. This trust is essential to scale up the use of AI and other relevant technology interventions to provide better care for more people." Key findings from FHI 2025 India report: Empowering the Healthcare Workforce With 75% of respondents saying AI-supported training is helpful for less experienced staff, especially in underserved areas, the opportunity to build a future-ready workforce is clear. Indian healthcare professionals view AI as a catalyst for clinical learning, skill-building, and co-developing solutions tailored to real-world healthcare challenges. 78% believe AI can ensure greater consistency in patient examinations, which could help address the issue of standardising care. 87% believe AI can improve access to clinical research 72% say AI can enable accurate and timely interventions While over half (56%) of HCPS in India are already contributing to AI development within their organizations, only four in ten feel these tools align with their day-to-day clinical needs, underscoring the need for more inclusive, hands-on collaboration in shaping technology that delivers meaningful impact. Optimising Care Every Step of the Way From triage to time-saving automation,76% of Indian healthcare professionals believe AI can direct patients to the appropriate care setting, enhancing access while enhancing limited healthcare resources. 78% believe AI can help reduce patients' wait times 60% say it can increase face-to-face time with patients 80% see AI as a way to automate repetitive tasks, which will help reduce administrative burden 65% believe AI can shorten procedure times Caution meets optimism: Addressing key limitations While the outlook is optimistic, several critical gaps must be bridged to realise the full potential of AI in Indian healthcare: 45% of HCPs want clear guidelines on AI usage and its limitations. 44% seek greater clarity on legal liability when using AI in patient care. 31% are looking for reassurance about data security. In addition, 67% express concern that data bias in AI tools could widen healthcare disparities. As the nation advances on its digital health journey, with the right partnerships and policies in place, India is well-positioned to lead the way in demonstrating how technology and trust can together shape a healthier, more equitable future. For more information, download the full FHI 2025 India Report here. Here's the news Center link: Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash
Business Wire
25-06-2025
- Business
- Business Wire
Methodist Hospitals Selects Philips to Advance Neurovascular, Cardiology and Complex Interventional Radiology Services in Northwest Indiana
CAMBRIDGE, Mass. & GARY, Ind.--(BUSINESS WIRE)-- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Methodist Hospitals today announced the healthcare provider's strategic investment in Philips' advanced portfolio of image-guided therapy (IGT) solutions that integrate imaging systems and software, with specialized diagnostic and therapeutic devices. The new interventional suites will support critical health needs within the community including active stroke treatment, oncology therapies, complex cardiovascular intervention and care for other prevalent health conditions. Methodist Hospitals will utilize one Philips Azurion biplane for both routine and complex procedures – such as active stroke intervention – designed to speed up and improve minimally invasive treatment. The health system will also standardize care on two single plane labs for cardiovascular care and a multi-purpose lab for complex cardiovascular and interventional radiology procedures. The Philips Azurion system has been shown to improve operational and clinical efficiency in the interventional suite while maintaining high quality care and staff satisfaction, including a 17% reduction in procedure time, providing the ability to treat one more patient per day [1]. 'Having leading edge health technology is crucial to delivering on our mission to be the best place for employees to work, for patients to receive care and for physicians to practice medicine,' said Matt Doyle, President & Chief Executive Officer, Methodist Hospitals. 'Philips' trusted solutions will empower us to deliver exceptional care to our patients close to home. Our collaboration with Philips enables us to maintain the highest standards of care now and into the future, reinforcing our commitment to excellence in healthcare delivery.' Methodist Hospitals is an award-winning healthcare provider that offers comprehensive services including emergency care, surgical services, oncology and cardiology, and is home to the Heart and Vascular Institute and NeuroScience Institute. The health system has more than 500 inpatient beds and more than 400 physicians and allied health professionals. 'These new interventional suites represent a significant step forward in fulfilling Methodist Hospitals' commitment to providing the highest level of care for every patient they serve,' said Jeff DiLullo, Chief Region Leader, Philips North America. 'Philips is proud to support these clinicians in making the right decisions faster, treating more patients more effectively, and achieving better health outcomes for their community with some of the most advanced interventional suites in the industry. We look forward to working closely with Methodist Hospitals to continue to transform the health of citizens in Northwest Indiana.' The Philips Azurion Image-Guided Therapy System with FlexArm and ClarityIQ technology provides exceptional imaging with reduced X-ray dose [2], improved workflow and more efficient turnaround times [1], offering a high level of clinical confidence. Methodist Hospitals will also benefit from Philips' IntraSight with SyncVision for IVUS imaging and additional physiology and interventional tools to simplify complex interventions, speed routine procedures and provide improved patient care [3,4]. Control of all compatible applications from a single touchscreen at the tableside helps clinicians make fast and informed decisions without breaking sterility. [1] Results from study conducted at St. Antonius Hospital. Results verified by NAMSA, independent third-party expert on study design and analytics. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. [2] In 37 individual comparative studies, Philips ClarityIQ was associated with reductions in patient radiation exposure. The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional radiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task. [3] Rao, Sunil V et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, S0735-1097(24)10424-X. 27 Feb. 2025, doi:10.1016/ [4] Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129. 2024. About Methodist Hospitals Methodist Hospitals is a community-based, not-for-profit health system with two full-service acute care facilities in Gary and Merrillville, Indiana, that has been healing Northwest Indiana for more than 100 years. Methodist Hospitals offers a number of award-winning programs, including its Breast Care Center, Cancer Center and Neuroscience and Heart and Vascular Institutes. Its range of services also includes Women & Children's Services, Bariatric Surgery services, Emergency services, Immediate Care Centers, Orthopedics & Spine services, comprehensive Rehabilitation services, Behavioral Health and Home Health services. About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at *The opinions and clinical experiences presented herein are specific to the featured topic(s) and are not linked to any specific patient and are for information purposes only. The medical experience(s) derived from specified topic(s) may not be predictive of all patients. Individual results may vary depending on a variety of patient-specific attributes and related factors. Nothing in this news announcement is intended to provide specific medical advice or to take the place of written law or regulations.
Business Wire
23-06-2025
- Business
- Business Wire
Prosus Accelerates Growth and Profitability, with 12X Improvement in Ecommerce Adjusted EBIT and 100% Increase in Dividend
AMSTERDAM & JOHANNESBURG--(BUSINESS WIRE)--Prosus N.V. (Prosus) (AEX and JSE: PRX) delivered a strong performance during a transformative year. We have exceeded our profitability targets, as we build the leading lifestyle ecommerce company in Latin America, Europe and India, driven by AI and innovation. Ecommerce revenue growth of 21%, to US$6.2bn. Adjusted EBIT increased twelve times to US$443m, ahead of guidance. iFood aEBIT grew 178%, OLX aEBIT up 61% and eMAG achieved profitability. Free cash flow positive for the first time, excluding Tencent. 100% increase in dividend to €0.20. US$7.8bn 1 invested to strengthen our regional ecosystems and expand portfolio of AI-native startups. Buybacks 2 returned over US$50bn, driving 15% NAV per share accretion. Fabricio Bloisi, Prosus CEO, Prosus and Naspers said: 'Prosus is rapidly transforming into an operating technology company, focused on lifestyle ecommerce, and powered by innovation and collaboration. This past year, we announced two significant deals to strengthen our regional ecosystems. We completed the acquisition of Despegar in May 2025 and are already integrating its products into iFood's Clube membership. We are making good progress with the purchase of Just Eat which will create a new AI-powered tech champion in Europe. 'I believe that truly great companies are shaped by their culture. Through 'The Prosus Way', we've implemented a cultural model that empowers our teams to deliver exceptional customer experiences through discipline, innovation and adopting an AI-first mindset. In the face of unprecedented technological disruption, we are now more connected and innovative than ever before. I'm confident that our enhanced culture and ecosystem approach, powered by Prosus, will fuel our journey to create the next US$100bn in value.' Nico Marais, Prosus CFO, commented: 'Prosus has delivered a strong financial performance over the past year, with topline growth in our operating businesses at double the rate of our peers. Ecommerce profitability has improved meaningfully from US$38m in FY24, to aEBIT of US$443m, ahead of our guidance. We expect this momentum to continue, and to add at least the same level of incremental aEBIT in FY26. FY2025 marks the first year that Prosus is free cash flow positive, excluding the Tencent dividend, with a free cash flow improvement of US$513m. As our financial position strengthens, we're able to share more with our shareholders, and have proposed a 100% increase in our dividend, to €0.20. Our disciplined capital allocation and strong balance sheet positions us well to execute on our ecosystem strategy.' Group performance Peer-leading growth and accelerating profitability across Ecommerce portfolio Food Delivery: iFood delivers world-class performance, exceeding growth and profitability targets and drives innovation and ecosystem expansion iFood delivered strong top line growth, with Gross Merchandise Value (GMV) up 32%, orders up 29% and revenue increasing 30%. iFood's core food delivery business grew aEBIT by 71% to US$306m, improving aEBIT margin to 27%; performance driven by higher ad revenues, increased order frequency and retention driven by iFood's Clube loyalty programme, and investments in its merchant platform. iFood's growth initiatives grew revenue by 34%, driven by strong performance in its groceries marketplace and credit businesses. Overall, iFood achieved a record profit, with aEBIT of US$226m, up 178%. Delivery Hero grew GMV by 8% for FY24, with revenue up 24%, boosting profitability to an adjusted EBITDA of €693m (from €254m in FY23). From January to December 2024, Swiggy grew Gross Order Value (GOV) by 29%, while adjusted EBITDA losses reduced to US$182m, from US$261m in the prior year. In Q125, Swiggy delivered GOV growth of 40% year-on-year, and quick commerce GOV growth of 101% year-on-year, with 316 new dark stores added in the quarter. Classifieds – OLX Group: Strong performance, with a significant jump in profitability and expanding margins OLX consolidated revenue grew 18%, with standout performances by motors and real estate verticals. Motors and real estate grew revenue 24% and 23% respectively, through improved monetisation, innovative product development and new trust-building initiatives within motors, and product enhancements within real estate. aEBIT accelerated by 61% to US$270m, with aEBIT margin up 10pp, to 35%. Payments & Fintech – PayU: Strong topline growth and improving profitability, despite challenging market conditions India payments TPV 5 increased by 17%, and revenues by 14%; aEBIT loss of US$12m reflects increased competition, resulting in lower take rates. India payments achieved breakeven in H2. India credit grew its loan book by 19% and revenues by 63%; aEBIT loss of US$32m impacted by higher costs and increased consumer loan book losses. Iyzico grew revenues 87% to US$288m, while aEBIT of US$18m at a margin of 6% reflected rising interest rates and investments in strategic growth initiatives. Overall, PayU's aEBIT losses improved by >100% to US$11m. Etail: eMAG achieved target of overall profitability for FY25 Strong growth with GMV up 9%, and revenue up 12% to US$2.5bn. aEBIT improved by US$40m to US$14m; includes one-off costs in Hungary in H1. Improved performance due to good growth in Romanian etail, and emerging logistics and grocery businesses Please note: Group results are shown on a consolidated basis from continuing operations, which reflect all majority owned and managed businesses. All OLX Autos business units are classified as discontinued operations, in line with IFRS disclosures. All growth percentages shown here are in local currency terms, excluding the impact of acquisitions and disposals (M&A), unless otherwise stated. Growth percentages shown here for all non-financial key performance indicators compare FY25 to FY24. Expand For full details of the Group's results, please visit
Yahoo
17-06-2025
- Business
- Yahoo
The Netherlands Associations for Investor Relations (NEVIR) announces the nominees for the 18th Annual Dutch IR Awards
Amsterdam, the Netherlands, June 12, 2025: The Netherlands Association for Investor Relations (NEVIR) is proud to announce the nominations for the 18th Annual Dutch IR nominees are: AEX Company of the Year ASML Holding ASR Nederland Shell AEX IR Professional of the Year Marcel Kemp, ASML Holding Michel Hulters, ASR Nederland Robin van den Broek, NN Group AMX Company of the Year CTP Just Eat Royal Vopak AMX IR Professional of the Year Rutger Relker, Aalberts Maarten Otte, CTP Fatjona Topciu, Royal Vopak AScX Company of the Year Alfen Avantium Wereldhave AScX IR Professional of the Year Aarne Luten, Avantium Floor van Maaren, ForFarmers Inge Laudy, PostNL Best ESG Engagement ASR Nederland Royal Ahold Delhaize Unilever Best Investor Event ASR Nederland Royal Ahold Delhaize Shell Best IR Website AkzoNobel KPN Philips Most Improved Company (IR Programme) Adyen Corbion Exor Young IR Talent Valentina Fantigrossi, ASM International Lennart Scholtus, Heineken Company Thomas Turnock, NN Group The Dutch IR Awards celebrates the achievements of individuals and companies of Dutch stock-listed companies across nine categories; ranging from Best IR professional and Company, to Best Investor Event. The nominations for the Dutch IR Awards are based on European research by Extel and incorporate feedback from global buy and sell-side professionals. The 2025 awards ceremony will be held on Thursday, July 3 in Amsterdam. SPONSORS We would like to extend our gratitude to our 2025 Dutch IR Awards sponsors: Platinum: ABN AMRO and ODDO BHF, CMi2i, Computershare Georgeson, Euronext Corporate Solutions, Ingage, ING Gold: FGS Global, Nasdaq, Notified Silver: S&P Global Market Intelligence, Tangelo Sponsoring through services / products: Extel and NFGD The publication of this press release has been made possible by GlobeNewswire. For media enquiries: Heather Robertson and Jonathan Berger secretariaat@ About the NEVIR: The Netherlands Association for Investor Relations (NEVIR), is the professional representative body and advocacy organisation for all members of Investor Relations teams at Dutch listed companies and consultants in the field of Investor in to access your portfolio
Korea Herald
12-06-2025
- Health
- Korea Herald
Philips Future Health Index 2025: Delayed care and lost clinical time call for accelerated AI adoption in APAC
SINGAPORE, June 12, 2025 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released the Asia Pacific (APAC) findings from its 10th annual Future Health Index (FHI) report, the largest global healthcare survey of its kind. The report draws insights on key concerns from healthcare professionals and patients in 16 countries, including Australia, Indonesia, and South Korea. Findings show that despite strong optimism about artificial intelligence's (AI) potential to ease pressure on APAC's healthcare systems, trust and implementation concerns persist. "The need for AI has never been greater. Our survey shows that patients are anxiously waiting more than a month for specialist care, while some healthcare professionals are losing about four working weeks of clinical time a year due to incomplete patient data," said Jasper Westerink, Senior Vice President and Representative Director of Philips Japan and Acting Managing Director of Philips APAC. "There is a clear role for AI to help clinicians act faster, make better decisions, and anticipate patient needs earlier as we strive to deliver better care for more people." Worsening patient outcomes because of care delays call for accelerated AI adoption About two in three patients (66%) surveyed in APAC are waiting nearly one and a half months to see a specialist doctor, with an average waiting time of 47 days. Generally, one in three patients (33%) in APAC report that their health has deteriorated due to delays in seeing a doctor, with one in four (25%) ultimately going to the hospital as a result of long waiting times. AI has the potential to transform care delivery and significantly improve patient outcomes across APAC. Workforce challenge and data burdens call for AI relief Three in four healthcare professionals (76%) in APAC report losing valuable clinical time due to incomplete or inaccessible patient data, with close to one-third (31%) of these losing over 45 minutes per shift, adding up to 23 full days a year lost by each professional. Similarly, two in five (39%) clinicians say they are now spending less time with patients and more time on administrative tasks than they were five years ago. These exacerbate the workforce challenge experienced by healthcare professionals in APAC, as estimated by the World Health Organization. The shortage of health workers in Southeast Asia alone will be 6.9 million respectively in 2030, nearly 40% of the global shortage burden. [1] About 300 healthcare professionals surveyed shared the following concerns if AI is not implemented: Addressing AI concerns from HCPs and patients crucial for widespread adoption A majority of healthcare professionals (81%) in APAC are involved in developing new technology at their organizations. However, 39% believe that the new technologies developed are not catered to their needs. Concerns around accountability persist, with 71% sharing concerns about the legal liability for AI usage, while 66% worry that potential data biases in AI applications could widen disparities in health outcomes. Among patients, a majority (75%) welcome the increased use of technology if it improves access to care and benefits them. Around half are concerned that it could reduce face-to-face time with their doctors (51%) and are worried about data security when new technologies are introduced in healthcare (54%). Trust key to transforming healthcare in APAC For the majority of healthcare professionals surveyed (84%) building trust in AI has to involve support with guidelines, issues and liability. In addition, healthcare professionals cite the development of evidence-based, transparent, and monitored AI solutions (72%), followed by reassurance on data security issues, with 51% of healthcare professionals seeking clarity in this area. For patients, about three in four (74%) welcome the use of more technology in healthcare if it helps make it easier to see a healthcare professional and if it helps improve care for patients like themselves (75%). Healthcare professionals play a key role in building trust between patients and AI. Majority of patients (86%) would feel more comfortable with AI in healthcare if hearing about it from their doctors, indicating that doctors are a trusted source of information about such technologies. "It's essential to foster trust of AI-powered technologies among healthcare professionals and patients," said Jasper. "This will enable widespread adoption and effective implementation. Industry-wide collaboration will help us address trust gaps to unlock AI's full potential, enabling responsible, inclusive integration across APAC's healthcare systems." For details on the Future Health Index methodology and to access the full Future Health Index 2025 report, visit Future Health Index | Philips. About the Future Health Index 2025 The Future Health Index is the largest global survey of its kind, analyzing the priorities and perspectives of healthcare professionals and patients across multiple countries. The Future Health Index 2025 investigates how innovative technologies, particularly AI, can empower healthcare professionals to deliver better care to more people. For more information, or to download the full FHI 2025 Global Report, visit About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at
